Brittany has over 20 years of experience in healthcare commercialization, including the first-ever digital medicine system approved by the FDA in 2017. She has led health system collaborations to implement emerging technologies in Alzheimer’s disease and related dementia and Serious Mental Illness. She also serves as a collaborator to the Davos Alzheimer’s Collaborative – Health System Preparedness initiative and is a core team member of the CEOi Blood-Based Biomarker Workgroup. Brittany was named as a 2022 National Institute of Aging (NIA) Finalist in the Healthy Aging Start-up Challenge and recently joined the Brain Watch Coalition as the international launch partner for a demonstration project for the adoption of clinical decision Intelligence applications in health systems.